Exceptional care, groundbreaking research
The Washington University NF Center is focused on accelerating the pace of scientific discovery and its application to the care of individuals with NF.
David H. Gutmann, MD, PhD, the Donald O. Schnuck Family Professor and director of the Neurofibromatosis Center at Washington University School of Medicine in St. Louis, received a $3.5 million grant to study why people with the same genetic mutation develop markedly different signs and symptoms.
Glioblastoma (GBM) are the most malignant brain tumor in adults, with over 13,000 people in the United States dying from these cancers each year. Read more about how Dr. Yuan Pan, and her colleagues at the Washington University NF Center, focused research on how tumor growth in this class of GBM is controlled.
Miranda Ehrstein was diagnosed with Neurofibromatosis type 1 (NF1) when she was just 18 months old. Now she is an outgoing and enthusiastic 12 year old girl, who loves stuffed animals, Science and swimming, and is determined to never let her NF1 hold her back. Read about Miranda’s journey with NF1, through the eyes of her loving family.
Apr 20, 2017
This article, written by Tamara Bhandari, originally appeared in the Washington University School of Medicine News Hub on April 13,...
Apr 14, 2017
Glioblastoma (GBM) are the most malignant brain tumor in adults, with over 13,000 people in the United States dying from...
Mar 13, 2017
Michelle Wegscheid is an MD/PhD trainee in the Neurosciences Program at Washington University. She graduated from the University of Illinois...